CD36 and metabolic dysfunction-associated steatotic liver disease: Specifically, GNMT, platelet glycoprotein-4 (CD36), and acyl-coenzyme A thioesterase 9 (Acot9) are involved in lipid metabolism and have previously been associated with human NAFLD progression [7,27,28,29].